DADE Dade Behring Holdings (MM)

Dade Behring Inc. (NASDAQ:DADE), the world's largest company solely dedicated to clinical diagnostics, and MedAssets Supply Chain Systems, one of the leading health care group purchasing organizations in the United States, have announced the signing of a three-year agreement that provides MedAssets' customers with access to Dade Behring's chemistry and automation products. The agreement includes an option for a two-year extension. Under the agreement, MedAssets' customers will have continued access to Dade Behring's full line of Dimension� chemistry systems. New additions to the agreement include the recently introduced Dimension Vista� 1500 Intelligent Lab System and Dade Behring's scalable automation systems�the StreamLAB� and Dimension� Lynx analytical workcells. "Dade Behring is pleased to continue this long-term relationship with MedAssets and its customers," said Jim Reid-Anderson, Chairman, President and CEO, Dade Behring. "The addition of our flexible laboratory automation systems provides a customized approach to automation, allowing clinical laboratories the opportunity to increase productivity in their laboratory." Dade Behring and MedAssets also have pre-existing agreements for the remainder of Dade Behring's product portfolio. The existing agreements include customer access to the Stratus� CS Acute Care� Diagnostic System and the Syva� drug testing, plasma protein, MicroScan� microbiology and coagulation product lines. About Dade Behring With 2006 revenue of more than $1.7 billion, Dade Behring is the world's largest company solely dedicated to clinical diagnostics. It offers a wide range of products, systems and services designed to meet the day-to-day needs of clinical laboratories, delivering innovative solutions to customers and enhancing the quality of life for patients. Additional company information is available on the Internet at www.dadebehring.com. About MedAssets MedAssets partners with healthcare providers to improve operating margins and cash flow while supporting quality of care goals. MedAssets implements integrated solutions to address the greatest opportunities for financial and process improvement and drives performance in revenue cycle, supply chain and clinical service line management. MedAssets is a business partner to more than 2,400 hospitals and 30,000 non-acute care healthcare providers. For more information, go to www.medassets.com. This press release may contain "Forward-Looking Statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward statements include information regarding the intent, belief or current expectation of the company and members of its senior management team, including, without limitation, expectations regarding prospective performance and opportunities and the outlook for the company's businesses, performance, opportunities and regulatory approval. In addition, the company is in the process of a major new product launch, which involves risks and uncertainties regarding product performance, costs of introduction and support, and customer acceptance. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by the company.